Alabama Medical Cannabis Dispensaries Set to Open After 5 Years of Delays

A Five-Year Journey Plagued by Lawsuits and Licensing Chaos

Alabama Governor Kay Ivey signed the Darren Wesley "Ato" Hall Compassion Act into law in May 2021, creating a framework for a regulated medical cannabis program. At the time, advocates expected patients to have access to products by spring 2023. That timeline quickly fell apart.

The Licensing Collapse

The Alabama Medical Cannabis Commission began accepting license applications and initially awarded permits in 2022. But the process was immediately challenged in court after allegations surfaced of "potential inconsistencies" in how applications were scored.

The commission made the unusual decision to void its initial license awards entirely and start over from scratch.

Years of Legal Limbo

What followed was a cascade of lawsuits, regulatory suspensions, and bureaucratic delays. Companies that had invested millions in facilities and compliance were left in limbo. Patients with qualifying conditions continued to go without legal access.

At various points, the program appeared on the verge of collapse.

NORML Deputy Director Paul Armentano captured the frustration, noting that for nearly five years, Alabama patients and their providers have lacked the ability to locally access medically necessary state-approved cannabis products from state-licensed dispensaries.

The Dispensary Landscape: 12 Locations Across the State

In January 2026, the AMCC finally issued dispensary licenses to three companies -- CCS of Alabama, GP6 Wellness, and RJK Holdings AL -- each authorized to operate three retail locations. A fourth license was later awarded to Yellowhammer Medical Dispensaries, bringing the total to 12 planned dispensary locations.

Where the Dispensaries Will Be Located

• CCS of Alabama ("Callie's") -- Birmingham, Montgomery, and Mobile
• GP6 Wellness -- Athens, Cullman, and Attalla
• RJK Holdings AL -- Daphne, Oxford, and Talladega
• Yellowhammer Medical Dispensaries -- Filling remaining gaps in the state's coverage map

Who Opens First?

CCS of Alabama, operating under the retail brand "Callie's," is expected to be the first to open its doors. According to the AMCC's general counsel Justin Aday, the company has been the most aggressive in completing its facility buildout and securing product inventory.

When Callie's opens -- potentially as early as April -- it will be the first place in Alabama where patients can legally purchase medical cannabis products.

What Products Will Be Available?

Alabama's medical cannabis program is notably restrictive compared to those in other states. The program regulates only non-herbal formulations of cannabis, meaning patients will not have access to smokable flower.

Available Product Types

• Tablets and capsules
• Tinctures
• Transdermal patches
• Suppositories
• Topical creams
• Nebulizer-compatible formulations

While these delivery methods may be unfamiliar to patients accustomed to traditional cannabis consumption, they align with Alabama's legislative intent to treat medical cannabis as a pharmaceutical product rather than a recreational one.

The absence of flower and vape products will likely keep Alabama's program smaller and more specialized than programs in neighboring states like Mississippi, which permits smokable cannabis for medical patients. However, for patients with severe conditions who have exhausted other treatment options, even limited product access represents a significant step forward.

Qualifying Conditions and Patient Access

Alabama's program covers a range of debilitating medical conditions. Patients must obtain a recommendation from one of the currently 20 state-certified physicians authorized to issue cannabis authorizations.

Qualifying Conditions

• Chronic pain
• Cancer-related cachexia
• Crohn's disease
• Depression
• Epilepsy and seizure disorders
• HIV/AIDS-related nausea
• PTSD
• Sickle cell anemia
• Spasticity from conditions like multiple sclerosis
• Terminal illness

Access Bottlenecks

The certification process has been another bottleneck. With just 20 doctors certified statewide, access remains geographically uneven, particularly in rural areas.

Patients must register with the AMCC and receive a medical cannabis card before making purchases. The commission has been working to streamline the patient registration process in anticipation of dispensaries opening, but details on pricing and insurance coverage remain to be fully established.

What This Means for the South

Alabama's dispensary launch arrives at a pivotal moment for cannabis policy in the American South.

The Changing Southern Landscape

• Georgia recently passed its SB220 bill expanding medical cannabis access
• Mississippi dispensaries have been operating since early 2024
• Louisiana has had a functioning medical program for years
• Virginia just passed recreational sales legislation

The Deep South is no longer a cannabis policy desert, though it remains a patchwork of restrictive programs with significant limitations. Alabama's non-flower, non-vape approach represents one end of the spectrum -- cautious, pharmaceutical-oriented, and tightly controlled.

For the estimated tens of thousands of Alabama residents with qualifying conditions, none of those policy debates matter as much as the practical reality of finally having legal access to cannabis products. The five-year wait has tested patience and strained trust in the regulatory process. Now, as dispensary buildouts near completion and product inventories are assembled, the state's medical cannabis program is on the verge of becoming a reality.